NPS: Medical Consequences Associated with Their Intake
- PMID: 27272067
- DOI: 10.1007/7854_2016_15
NPS: Medical Consequences Associated with Their Intake
Abstract
Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including medications, now being used in novel ways. By the end of 2014, in excess of 500 NPS had been reported by a large number of countries in the world. Most recent data show, however, that synthetic cathinones, synthetic cannabinoids, and psychedelics/phenethylamines account for the largest number of NPS.The present chapter aims at providing an overview of the clinical and pharmacological issues relating to these most popular NPS categories. Given the vast range of medical and psychopathological issues associated with the molecules here described, it is crucial for health professionals to be aware of the effects and toxicity of NPS. A general overview of the acute management of NPS adverse events is provided as well, although further studies are required to identify a range of evidence-based, index molecule-focused, treatment strategies. The rapid pace of change in the NPS online market constitutes a major challenge to the provision of current and reliable scientific knowledge on these substances.
Keywords: Drug misuse; Hallucinogenic drugs; Hallucinogens; Novel psychoactive substances; Phenethylamines; Psychiatric disturbances; Synthetic cannabimimetics; Synthetic cathinones.
Similar articles
-
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.Expert Rev Clin Pharmacol. 2016 Jul;9(7):943-54. doi: 10.1586/17512433.2016.1167597. Epub 2016 Apr 4. Expert Rev Clin Pharmacol. 2016. PMID: 26985969 Review.
-
Next generation of novel psychoactive substances on the horizon - A complex problem to face.Drug Alcohol Depend. 2015 Dec 1;157:1-17. doi: 10.1016/j.drugalcdep.2015.09.030. Epub 2015 Oct 9. Drug Alcohol Depend. 2015. PMID: 26482089 Review.
-
The clinical challenges of synthetic cathinones.Br J Clin Pharmacol. 2020 Mar;86(3):410-419. doi: 10.1111/bcp.14132. Epub 2020 Feb 3. Br J Clin Pharmacol. 2020. PMID: 31674690 Free PMC article.
-
I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.Int J Drug Policy. 2017 Feb;40:44-49. doi: 10.1016/j.drugpo.2016.11.004. Epub 2016 Dec 8. Int J Drug Policy. 2017. PMID: 27939599
-
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.Medicina (Kaunas). 2021 Jun 6;57(6):580. doi: 10.3390/medicina57060580. Medicina (Kaunas). 2021. PMID: 34204131 Free PMC article. Review.
Cited by
-
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction.Front Psychiatry. 2021 Apr 30;12:688434. doi: 10.3389/fpsyt.2021.688434. eCollection 2021. Front Psychiatry. 2021. PMID: 33995156 Free PMC article. No abstract available.
-
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.Neural Regen Res. 2020 May;15(5):802-816. doi: 10.4103/1673-5374.268895. Neural Regen Res. 2020. PMID: 31719240 Free PMC article. Review.
-
E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs.Adv Drug Alcohol Res. 2023 Jun 30;3:11345. doi: 10.3389/adar.2023.11345. eCollection 2023. Adv Drug Alcohol Res. 2023. PMID: 38389821 Free PMC article. Review.
-
Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon.Brain Sci. 2018 Dec 13;8(12):221. doi: 10.3390/brainsci8120221. Brain Sci. 2018. PMID: 30551554 Free PMC article.
-
The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.Front Psychiatry. 2019 Nov 20;10:851. doi: 10.3389/fpsyt.2019.00851. eCollection 2019. Front Psychiatry. 2019. PMID: 31849723 Free PMC article. Review.
References
-
- UNODC (United Nations Office on Drugs and Crime) (2015) World Drug Report. https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf . Accessed 30 Nov 2015
-
- EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2015) New psychoactive substances in Europe - an update from the EU Early Warning System. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances . Accessed 15 Nov 2015
-
- EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2015) Synthetic cannabinoids in Europe. http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids . Accessed 29 Nov 2015
-
- Daly M (2013) Streets legal. Druglink 28:17
-
- Shlosberg D, Zalsman G, Shoval G (2014) Emerging issues in the relationship between adolescent substance use and suicidal behavior. Isr J Psychiatry Relat Sci 51:262–267 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical